AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Lucid

Published October 28, 2026 · Updated October 29, 2026

Federal Health Officials Outline Pre-Approval Roadmap for Psychedelic Medicines at ... - Lucid News

Read the full story at Lucid

MDMA candidate for PTSD, which was recently pre-filed with the FDA. At the same time, compelling clinical data and favorable regulatory winds have.

Post on X

Share this story

Surfaced by this Google Alert

MDMA